AIBN Associate Professor Joy Wolfram believes decoding a cellular messaging system will give them the upper hand against a particularly deadly type of breast cancer.
AIBN researcher Dr Nick Fletcher has won an Advance Queensland Industry Research Fellowship to explore localised cell death and the immune response to cancer.
What can the metabolism of 606 people from China, the Netherlands and Australia tell us about the onset and progression of ALS? Turns out, quite a bit.
For three months Tahmina Tabassum relearned what she knew about industry and entrepreneurship during a placement with biotech Azafaros BV, a whirlwind experience that included a stint at the company’s headquarters in Basel.
AIBN researchers want HIV patients to have the option of taking a long-acting antiretroviral dose once a week, instead of having to take a dose every day.